Serum endocan levels in non-ST segment elevation myocardial infarction patients
BackgroundEndothelial dysfunction and inflammation play a key role in the pathophysiology of acute coronary syndrome (ACS). Endocan has emerged as a novel biomarker reflecting endothelial activation.ObjectiveTo investigate serum endocan levels in patients with non–ST-segment elevation myocardial inf...
Tallennettuna:
| Päätekijät: | , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2026-06-01
|
| Sarja: | Frontiers in Cardiovascular Medicine |
| Aiheet: | |
| Linkit: | https://www.frontiersin.org/articles/10.3389/fcvm.2026.1783106/full |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
